Hypoxia signalling controls metabolic demand

Current Opinion in Cell Biology

Volumn 19, Issue 2, 2007, Pages 223-229

  Brahimi Horn, M Christiane ^a   Chiche, Johanna ^a   Pouysségur, Jacques ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; LACTIC ACID; OXYGEN; TRANSCRIPTION FACTOR;

AEROBIC METABOLISM; ANAEROBIC METABOLISM; BREATHING RATE; CANCER CELL; CELL METABOLISM; GENE EXPRESSION REGULATION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HYPOXIA; LACTIC ACIDOSIS; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CELL HYPOXIA; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LACTIC ACID; MODELS, BIOLOGICAL; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION;

EID: 33847711354     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2007.02.003     Document Type: Review

References (49)

1. Brahimi-Horn M.C., and Pouyssegur J. The hypoxia-inducible factor and tumor progression along the angiogenic pathway. Int Rev Cytol 242 (2005) 157-213
2. Schofield C.J., and Ratcliffe P.J. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5 (2004) 343-354
3. Manalo D.J., Rowan A., Lavoie T., Natarajan L., Kelly B.D., Ye S.Q., Garcia J.G., and Semenza G.L. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105 (2005) 659-669
4. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3 (2003) 721-732
5. Gatenby R.A., and Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat Rev Cancer 4 (2004) 891-899
6. Pouyssegur J., Dayan F., and Mazure N.M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441 (2006) 437-443
7. Schofield C.J., and Ratcliffe P.J. Signalling hypoxia by HIF hydroxylases. Biochem Biophys Res Commun 338 (2005) 617-626
8. Peet D., and Linke S. Regulation of HIF: asparaginyl hydroxylation. Novartis Found Symp 272 (2006) 37-49 discussion 49-53, 131-140
9. Brahimi-Horn C., Mazure N., and Pouyssegur J. Signalling via the hypoxia-inducible factor-1α requires multiple posttranslational modifications. Cell Signal 17 (2005) 1-9
10. Bilton R, Trottier E, Pouysségur J, Brahimi-Horn MC: ARDent about acetylation and deacetylation in hypoxia signalling. Trends Cell Biol 2006, in press.
11. Denko N.C., Fontana L.A., Hudson K.M., Sutphin P.D., Raychaudhuri S., Altman R., and Giaccia A.J. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 22 (2003) 5907-5914
12. Kim W.Y., Safran M., Buckley M.R., Ebert B.L., Glickman J., Bosenberg M., Regan M., and Kaelin Jr. W.G. Failure to prolyl hydroxylate hypoxia-inducible factor α phenocopies VHL inactivation in vivo. EMBO J 25 (2006) 4650-4662
13. Gruber M., and Simon M.C. Hypoxia-inducible factors, hypoxia, and tumor angiogenesis. Curr Opin Hematol 13 (2006) 169-174
14. Dayan F., Roux D., Brahimi-Horn M.C., Pouyssegur J., and Mazure N.M. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor- 1α. Cancer Res 66 (2006) 3688-3698. A novel explanation for the selective function of the two transcriptional activation domains of the HIF-1α subunit.
15. ••], which came out simultaneously, demonstrate that HIF-1 down-regulates the TCA cycle activity through inhibition of pyruvate dehydrogenase.
16. ••].
17. Pouyssegur J., and Mechta-Grigoriou F. Redox regulation of the hypoxia-inducible factor. Biol Chem 387 (2006) 1337-1346
18. Vordermark D., Kraft P., Katzer A., Bolling T., Willner J., and Flentje M. Glucose requirement for hypoxic accumulation of hypoxia-inducible factor-1α (HIF-1α). Cancer Lett 230 (2005) 122-133
19. Lu H., Dalgard C.L., Mohyeldin A., McFate T., Tait A.S., and Verma A. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J Biol Chem 280 (2005) 41928-41939. The authors report that the primary and secondary glycolytic metabolites pyruvate and oxaloacetate inhibit PHDs by binding to their 2-OG sites.
20. Ramanathan A., Wang C., and Schreiber S.L. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc Natl Acad Sci USA 102 (2005) 5992-5997. This paper examines the metabolic changes associated with tumourigenic conversion.
21. Hammond E.M., and Giaccia A.J. The role of p53 in hypoxia-induced apoptosis. Biochem Biophys Res Commun 331 (2005) 718-725
22. Gottlieb E., and Tomlinson I.P. Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer 5 (2005) 857-866
23. King A., Selak M.A., and Gottlieb E. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 25 (2006) 4675-4682
24. Pollard P.J., Briere J.J., Alam N.A., Barwell J., Barclay E., Wortham N.C., Hunt T., Mitchell M., Olpin S., Moat S.J., et al. Accumulation of Krebs cycle intermediates and over- expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet 14 (2005) 2231-2239. The authors demonstrate a link between FH and SDH mutations and HIF-1a expression in tumours.
25. Dahia P.L., Ross K.N., Wright M.E., Hayashida C.Y., Santagata S., Barontini M., Kung A.L., Sanso G., Powers J.F., Tischler A.S., et al. A HIF1α regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet 1 (2005) 72-80. The authors describe a link between mutations in the tumour suppressors VHL and SDH and HIF-1 activation through the oxidoreductase function of the SHDB subunit of mitochondrial complex II, a component of the electron transport chain.
26. Kaelin Jr. W.G. ROS: really involved in oxygen sensing. Cell Metab 1 (2005) 357-358
27. Plas D.R., and Thompson C.B. Akt-dependent transformation: there is more to growth than just surviving. Oncogene 24 (2005) 7435-7442
28. Schieke S.M., Phillips D., McCoy Jr. J.P., Aponte A.M., Shen R.F., Balaban R.S., and Finkel T. The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem 281 (2006) 27643-27652. The authors show by direct measurement of oxygen consumption the involvement of mTOR in mitochondrial respiration.
29. Kim J.W., and Dang C.V. Multifaceted roles of glycolytic enzymes. Trends Biochem Sci 30 (2005) 142-150
30. Blum R., Jacob-Hirsch J., Amariglio N., Rechavi G., and Kloog Y. Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1α, causing glycolysis shutdown and cell death. Cancer Res 65 (2005) 999-1006
31. Koukourakis M.I., Giatromanolaki A., Simopoulos C., Polychronidis A., and Sivridis E. Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer. Clin Exp Metastasis 22 (2005) 25-30
32. Fantin V.R., St-Pierre J., and Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9 (2006) 425-434. LDH-A knockdown tips the metabolic balance toward OXPHOS and significantly diminishes tumour growth.
33. Pelicano H., Martin D.S., Xu R.H., and Huang P. Glycolysis inhibition for anticancer treatment. Oncogene 25 (2006) 4633-4646
34. Kondoh H., Lleonart M.E., Gil J., Wang J., Degan P., Peters G., Martinez D., Carnero A., and Beach D. Glycolytic enzymes can modulate cellular life span. Cancer Res 65 (2005) 177-185
35. Matoba S., Kang J.G., Patino W.D., Wragg A., Boehm M., Gavrilova O., Hurley P.J., Bunz F., and Hwang P.M. p53 regulates mitochondrial respiration. Science 312 (2006) 1650-1653. Cytochrome c oxidase 2 is identified as a downstream mediator of the balance between respiration and glycolysis.
36. Bensaad K., Tsuruta A., Selak M.A., Vidal M.N., Nakano K., Bartrons R., Gottlieb E., and Vousden K.H. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126 (2006) 107-120. This study identifies a novel gene induced by p53 termed TP53-induced glycolysis and apoptosis regulator (TIGAR) that shows similarity to 6-phosphofructo-2-kinase/fructose-2,6, bisphosphatase. Over-expression leads to a reduction in the level of fructose-2,6-bisphospate and inhibition of glycolysis.
37. Gerweck L.E., Vijayappa S., and Kozin S. Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics. Mol Cancer Ther 5 (2006) 1275-1279
38. Gatenby R.A., Gawlinski E.T., Gmitro A.F., Kaylor B., and Gillies R.J. Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res 66 (2006) 5216-5223
39. Walenta S., and Mueller-Klieser W.F. Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol 14 (2004) 267-274
40. Gutierrez G. A mathematical model of tissue-blood carbon dioxide exchange during hypoxia. Am J Respir Crit Care Med 169 (2004) 525-533
41. Izumi H., Torigoe T., Ishiguchi H., Uramoto H., Yoshida Y., Tanabe M., Ise T., Murakami T., Yoshida T., Nomoto M., et al. Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. Cancer Treat Rev 29 (2003) 541-549
42. Ullah M.S., Davies A.J., and Halestrap A.P. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha dependent mechansm. J Biol Chem 281 (2006) 9030-9037
43. Shimoda L.A., Fallon M., Pisarcik S., Wang J., and Semenza G.L. HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes. Am J Physiol Lung Cell Mol Physiol 291 (2006) L941-L949
44. Bobulescu I.A., Di Sole F., and Moe O.W. Na+/H+ exchangers: physiology and link to hypertension and organ ischemia. Curr Opin Nephrol Hypertens 14 (2005) 485-494
45. Counillon L., and Pouyssegur J. The expanding family of eucaryotic Na(+)/H(+) exchangers. J Biol Chem 275 (2000) 1-4
46. Proescholdt M.A., Mayer C., Kubitza M., Schubert T., Liao S.Y., Stanbridge E.J., Ivanov S., Oldfield E.H., Brawanski A., and Merrill M.J. Expression of hypoxia-inducible carbonic anhydrases in brain tumors. Neuro-oncol 7 (2005) 465-475
47. Potter C., and Harris A.L. Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target. Cell Cycle 3 (2004) 164-167
48. Svastova E., Hulikova A., Rafajova M., Zat'ovicova M., Gibadulinova A., Casini A., Cecchi A., Scozzafava A., Supuran C.T., Pastorek J., et al. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett 577 (2004) 439-445. The authors demonstrate that CA IX is implicated in extracellular regulation of pH.
49. Dorai T., Sawczuk I.S., Pastorek J., Wiernik P.H., and Dutcher J.P. The role of carbonic anhydrase IX overexpression in kidney cancer. Eur J Cancer 41 (2005) 2935-2947. The revelation that CA IX not only possesses a catalytic function but modulates cell adhesion and proliferation through a growth factor receptor-like response.